# Prevention of the Hepatic Sinusoidal Obstruction Syndrome by Means of Anticoagulants

> **NCT00885950** · — · COMPLETED · sponsor: **Maastricht University Medical Center** · enrollment: 80 (actual)

## Conditions studied

- Sinusoidal Obstruction Syndrome
- Colorectal Liver Metastases

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00885950
- **Lead sponsor:** Maastricht University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2009-12
- **Final completion:** 2010-06
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2014-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00885950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00885950, "Prevention of the Hepatic Sinusoidal Obstruction Syndrome by Means of Anticoagulants". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00885950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*